Home/Pipeline/Supertendin 5 + 10

Supertendin 5 + 10

Not specified (cardiovascular/ICU)

ApprovedActive (Relaunch planned for 2026)

Key Facts

Indication
Not specified (cardiovascular/ICU)
Phase
Approved
Status
Active (Relaunch planned for 2026)
Company

About Carinopharm

Carinopharm is a commercial-stage, private pharmaceutical company based in Germany, specializing in hospital-based injectable therapies for acute care. Founded in 2015, it has established a commercial portfolio of small molecule drugs, including branded generics and some proprietary products, targeting cardiology and intensive/emergency care. The company operates a straightforward business model of development, manufacturing (via partners), and distribution of niche, essential medicines primarily to the German hospital market. Its outlook is tied to maintaining a reliable supply of critical care drugs and selectively expanding its portfolio.

View full company profile